TrueBlue (NYSE:TBI) Cut to Sell at StockNews.com

StockNews.com lowered shares of TrueBlue (NYSE:TBI - Free Report) from a hold rating to a sell rating in a research report sent to investors on Thursday.

Separately, BMO Capital Markets lowered their target price on TrueBlue from $11.00 to $10.00 and set an "outperform" rating for the company in a report on Tuesday, November 5th.

TrueBlue Price Performance

Shares of TrueBlue stock traded down $0.06 on Thursday, hitting $7.27. The company had a trading volume of 132,102 shares, compared to its average volume of 120,075. The stock has a 50-day moving average of $8.06 and a 200-day moving average of $7.99. TrueBlue has a twelve month low of $6.63 and a twelve month high of $13.61. The firm has a market capitalization of $214.78 million, a P/E ratio of -1.89, a P/E/G ratio of 3.66 and a beta of 1.42.

Hedge Funds Weigh In On TrueBlue

Several hedge funds have recently made changes to their positions in TBI. Quantbot Technologies LP bought a new stake in shares of TrueBlue in the third quarter worth $79,000. SG Americas Securities LLC acquired a new stake in TrueBlue in the 4th quarter valued at $108,000. Proficio Capital Partners LLC acquired a new stake in TrueBlue in the 4th quarter valued at $116,000. Quantinno Capital Management LP bought a new stake in TrueBlue during the 3rd quarter worth about $149,000. Finally, Algert Global LLC acquired a new position in shares of TrueBlue during the 2nd quarter worth about $208,000. 97.15% of the stock is owned by institutional investors.

TrueBlue Company Profile

TrueBlue, Inc, together with its subsidiaries, provides specialized workforce solutions in the United States, Canada, the United Kingdom, Australia, and Puerto Rico. It operates through three segments: PeopleReady, PeopleManagement, and PeopleScout. The company PeopleReady segment provides general, industrial, and skilled trade contingent staffing services for construction, transportation, manufacturing, retail, hospitality, and renewable energy industries.